I Stock 175399977 1

Navigate Federal Funding Uncertainty

CRF funding recipients must spend their allocated funds by December 30, 2020

Meeting the December 30, 2020 Deadline

COVID-19 Funding Experts are Advising on >$4B in Coronavirus Relief Funds on behalf of >50 state, county and city governments.


Earlier this year the CARES Act established a $150 billion Coronavirus Relief fund (CRF) available to cities and counties with populations over 500,000, US territories, and Tribal governments to cover expenses. Funding helps local governments recover from costs associated with the pandemic. However, navigating the CARES Act can be difficult. Local governments must understand how to access the funding and how to file grant applications, and they need to be able to do it quickly and accurately to ensure funding gets to where it’s needed.

Most importantly, as it stands today, on December 30, 2020 unused funds will revert to the federal government, however the government is considering extending the spending deadline. We offer our clients a twofold approach by ensuring they are utilizing this critical funding in the best, most effective way possible within the current prescribed timeline. In addition, we are advising them of longer term plans should the government choose to extend the deadline.


The CRF is a grant program for state, county and municipal governments and is subject to a federal audit process to ensure regulatory compliance – a process our experts know all too well. We help build your CRF grant management processes and systems as well as assess the audit-readiness of your program.

Contact Our Experts

Case Studies

I Stock 1220625113

JEFFERSON County Streamlines COVID-19 THROUGH CARES Act Funding ALLOCATION

We help counties fast-track the funding request evaluation and decision process by enlisting trusted healthcare and CARES funding experts to help prioritize projects, find efficiencies, eliminate duplication, and most importantly resolve stakeholder conflict.

Read the Case Study
I Stock 1205251422

Our Experts Help Lead the Sedgwick County’s COVID-19 Response

Witt O’Brien’s helped the county devise a comprehensive community assessment and Notice of Funding Opportunity to prioritize the needs of local governments and public and private sector entities.

Read the Case Study

What governments need to know about the CARES ACT

Witt O’Brien’s is currently supporting State and local governments across the United States optimize use of federal assistance, offering an experienced voice and force multiplier to help deliver timely and impactful COVID-19 programs and initiatives.

Learn More
I Stock 1218500406

Developing a Plan to Meet the Deadline

The CARES Act requires that payments from the CRF only be used to cover expenses that are necessary due to the public health emergency concerning the COVID–19. To further clarify, these costs most not have been accounted for in the government’s budget approved as of March 27, 2020 and all expenses must have been incurred during the period that begins on March 1, 2020 and ends on December 30, 2020 – therefore all funding must be use by the end of this year.

Watch Our Webinar
I Stock 939841380

Coronavirus Relief Fund Payroll Expense Eligibility Policy Brief

Funding is available for necessary, one-time expenses that were previously unbudgeted but incurred as a result of the COVID-19 pandemic. Fortunately, the overall guidance appears to allow broad flexibility to determine the appropriate use of payments received from the CRF. However, as it relates to payroll expenses, guidance indicates that only the costs of employees directly responding to the public health emergency are considered eligible payroll costs. This means other employees likely won’t be determined to be substantially dedicated to mitigating or responding to the public health emergency.

Witt O’Brien’s experts have a comprehensive understanding of cost recovery/funding optimization framework and have developed eligibility assessment tools to guide local governments in identifying the best fit for each COVID-19-related expense.

Learn More
I Stock 1151147354